Sri Venkata Gangadhara Pharma supplies Active Pharmaceutical Ingredients, API Intermediates, and NDDS Pellets to the worldwide generics market — with compliance at the core of everything we do.
21 high-purity APIs spanning cardiovascular, CNS, GI, anti-infective, and urology therapeutic areas for the global generics market.
APIsKey synthetic intermediates for 13 major APIs — supporting pharmaceutical manufacturers in building reliable supply chains with confidence.
IntermediatesNovel drug delivery system pellets (EC, IR, SR/MR) and directly-compressible granules enabling advanced oral dosage form development.
Pellets / NDDSWho we are: Sri Venkata Gangadhara Pharma is an India-based pharmaceutical company specialising in APIs, API Intermediates, and NDDS / Pellets for the global generics market.
Vision: To be a globally trusted pharmaceutical partner — known for quality, compliance, and long-term reliability in every supply relationship.
Mission: To deliver quality APIs and intermediates while maintaining the highest ethical and regulatory standards across every transaction.
Compliance focus: All products are aligned to cGMP and ICH guidelines with full documentation and traceability, supporting regulatory submissions worldwide.
Partnership approach: For product enquiries, regulatory documentation, or long-term supply partnerships, we provide dedicated support and documentation on request.
All manufacturing partners operate under cGMP-aligned quality systems with scheduled audits and CAPA protocols.
Full adherence to ICH Q7 (API GMP), Q3A/B (impurity guidelines), and related stability and analytical guidelines.
CoA, DMF, MSDS, and full batch traceability documentation provided with every shipment to support global regulatory submissions.
Technical support for ANDA, NDA, and EDMF filings — helping customers navigate global regulatory requirements with confidence.
Quality Policy: Sri Venkata Gangadhara Pharma is committed to sourcing and supplying pharmaceutical ingredients that consistently meet or exceed customer specifications and applicable regulatory requirements. We maintain robust supplier qualification, incoming quality control, and documentation practices to ensure every product delivered is fit for purpose and safe for patient use.
We work exclusively with cGMP-certified manufacturing facilities, each qualified through rigorous audits, SOPs, and ongoing performance monitoring.
Access to multi-step synthesis, pelletisation (extrusion-spheronisation, fluid-bed), enteric coating, and direct-compression granulation capabilities.
Reliable sourcing, stock management, and international shipping with cold-chain capability — ensuring product integrity from origin to destination.
Incoming material testing, in-process controls, and finished product analysis — including HPLC, dissolution, microbiology, and stability studies.
Comprehensive DMF support, CoA, MSDS, impurity profiles, and stability data packages to assist ANDA, NDA, and EDMF submissions globally.
Serving pharmaceutical manufacturers in Asia, Europe, the Americas, and Africa with understanding of local regulatory environments and market needs.